TopNewsOn
Health

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive

Meghana Keshavan and Adam Feuerstein·STAT News·November 20, 2026

Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:

Read the full story at STAT News →
STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive — TopNewsOn